ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
RecruitingNCT01301885
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Endometriosis is a chronic disease characterized by the presence of functional endometrial glands and stroma in ectopic locations outside the uterine cavity. The ectopic endometrial tissue responds to estradiol and other hormones similarly to the normal endometrium. Endometriosis is one of the most common benign gynecological conditions, as many as 5-10% of women in the reproductive age may be affected. In addition to pain which may be severe, subfertility is one of the typical problems associated with endometriosis and may be present in up to 40% of those affected. There is lack of a clear correlation between severity of pain and degree of compromised fertility. Different modes of treatment exist. Hormonal treatments are based on the suppression of estrogenic action on endometriosis as well as the endometrium. Unfortunately, discontinuation of the hormonal treatment typically results in a rapid recurrence of the disease. Surgery may alleviate the symptom for different lengths of time, however, curative treatment frequently involves hysterectomy with bilateral oophorectomy. In order to escape this radical treatment, new targeted therapy in the form of novel pharmacological agents would be of crucial importance. Presently, endometriosis can be reliably diagnosed only by laparoscopy. Since this is an invasive surgical procedure, new diagnostic tools would be warmly welcomed. Furthermore, as the progression of the disease is presently impossible to predict, new markers for the "malignancy" of each case are desperately needed. The aim of the investigators research is to identify expression of endometriosis specific RNAs/proteins. Evaluation of expression profiles in samples of endometriosis and endometrium of patients with careful clinical and surgical classification of endometriosis as well as healthy control women should initially enable to identify novel targets for new therapies and biomarkers. Particularly the different pain symptoms will be recorded annually and e…
Study details
- Official title
- Novel Diagnostic Tools for Endometriosis and Their Exploitation for Prognosis and Prevention of Complications
- Conditions
- Interventions
- Procedure: Laparoscopy/laparotomy
- Sponsor
- Turku University Hospital
- Collaborators
- University of Turku; The Finnish Funding Agency for Technology and Innovation; VTT Technical Research Centre of Finland; Finnish Medical Foundation; Hormos Medical; PerkinElmer, Wallac Oy; Biotop Oy; Pharmatest Services Ltd; Drug Discovery Graduate School, Finland; The National Graduate School of Clinical Investigation, Finland
- Start date
- 2005-10
- Primary completion
- 2025-12
- Sex
- Female
- Age range
- from 19 Years to 48 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Finland
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * study group: surgically and pathologically verified endometriosis * control group: existence of endometriosis ruled out in laparoscopy Exclusion Criteria: * no other significant disease or medication for other diseases * suspicion of malignancy * pregnancy * acute infection * insufficient understanding of Finnish language * previous hysterectomy and/or bilateral salpingo-oophorectomy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01301885